AIMCA
FOLD

Alberta Investment Management Corp (AIMCo)’s Amicus Therapeutics FOLD Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.1M Buy
1,389,200
+450,000
+48% +$6.45M 0.12% 114
2025
Q4 		$13.4M Buy
+939,200
New +$9.23M 0.08% 172
2023
Q3 		– Sell
-13,544
Closed -$170K – 1104
2023
Q2 		$170K Buy
+13,544
New +$161K ﹤0.01% 1158

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s FOLD Position: Q1 2026 in Review

Alberta Investment Management Corp (AIMCo) increased its Amicus Therapeutics (FOLD) stake by 48% in Q1 2026, buying an estimated $6.45M and bringing the position to 1,389,200 shares worth $20.1M. The position accounts for 0.12% of the portfolio, ranked #114.

Alberta Investment Management Corp (AIMCo) first reported a position in FOLD in Q2 2023 and has held it in 3 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Alberta Investment Management Corp (AIMCo) held 1,389,200 shares of Amicus Therapeutics worth $20.1M as of Q1 2026.
  • Alberta Investment Management Corp (AIMCo) bought 450,000 Amicus Therapeutics shares in Q1 2026, an estimated $6.45M.
  • Amicus Therapeutics made up 0.12% of Alberta Investment Management Corp (AIMCo)'s portfolio in Q1 2026, its #114 holding.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Amicus Therapeutics in Q2 2023 and has held it in 3 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2026, filed 29 Apr 2026.